Quick Answer
Nasus Pharma Ltd reported Earnings Per Share Diluted of $0.72 (loss) per share for the year ending 2025.
- Nasus Pharma Ltd showed a decrease of -227.3% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Nasus Pharma Ltd's annual report (Form 10-K), filed with the SEC on March 25, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 3 years of available data (2023 to 2025), Nasus Pharma Ltd's Earnings Per Share Diluted has declined by 260.0%.
- Historical annual values: Fiscal year 2025: $0.72 (loss) per share | Fiscal year 2024: $0.22 (loss) per share | Fiscal year 2023: $0.20 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: